Posts Tagged ‘cancer’

October Basic & Translation Sciences Seminar Series schedule

The Basic & Translational Sciences Seminar Series, co-sponsored by the Knight Cancer Institute and the Department of Cell & Developmental Biology, provides an emphasis on fundamental science and translational research topics presented by leading extramural scientists. Upcoming speakers in October: October 7 at 4 p.m. in Vollum room M1441 – Mark LaBarge, Ph.D., Lawrence Berkeley National Laboratory October 14 at 4 p.m. in Richard Jones Hall room 4320  – David Cheresh, Ph.D., University of California, … Read More

OHSU receives $25 million for clinical and translational pancreatic cancer research

This morning, OHSU announced a $25 million pledge from Norman and Linda Brenden and the Colson Family Foundation that will fund a cutting-edge, multidisciplinary research initiative to fight pancreatic cancer. The pledge is one of the top monetary gifts in the history of OHSU and one of the largest in the nation to fund studies on pancreatic health. Funds will be used to support a highly collaborative team of clinical researchers and basic scientists with … Read More

Join Team OHSU at Light the Night, Oct. 19

Join the OHSU Research Team for Light the Night on Saturday, October 19, a two-mile walk benefiting the Leukemia & Lymphoma Society. Several OHSU researchers have been recipients of LLS funding, including Knight Cancer Institute Director Dr. Brian Druker. Funding from LLS was vital in Dr. Druker’s breakthrough discovery of Gleevec, a drug used to fight chronic myeloid leukemia. The walk is free, family-friendly event. What: Light the Night When: Saturday, October 19, 2013. Doors … Read More

Knight Cancer and Cell & Developmental Biology seminar series merge

The Knight Cancer Institute Seminar Series has merged with the Cell & Developmental Biology Seminar Series to form a new Basic & Translational Sciences Seminar Series, sponsored by both the Knight Cancer Institute and CBD. Upcoming speakers in September: September 10 at 4 p.m. in room UHS 8B60 – Klaus H. Kaestner, Ph.D., University of Pennsylvania School of Medicine September 24 at 4 p.m. in room UHS 8B60 – Aykut Uren, M.D., Georgetown University Medical … Read More

CureSearch Walk with “Grimm” star, Aug. 10

The Doernbecher Knights are hosting a team at the Portland CureSearch Walk with special guest and team member Sasha Roiz from NBC’s “Grimm.” The walk will take place at Sellwood River Front Park from 9:30 a.m. to 12:00 p.m. on Saturday, August 10. Registration is available online or at 8:30 a.m. the day of the event. Proceeds from the walk will fund research to fight childhood cancer, some of which come directly back to OHSU Doernbecher’s Childhood Cancer … Read More

V Foundation cancer research funding, internal deadlines May 17 & 24

The V Foundation for Cancer Research has invited OHSU to submit applications for two of their research programs this cycle: The V Foundation Translational Myelodysplastic Syndromes Research Project Offers up to $400,000 over two years in support of a translational research project on Myelodysplastic Syndromes as it relates to people with or at risk for cancer. Deadlines Internal deadline: May 17, 2013 Letter of Intent: May 31, 2013 Full application (by invitation only): June 19, … Read More

Unique translational research training from American Society of Hematology

New scientists pursing a career in hematology may be interested in this unique year-long training opportunity from the American Society of Hematology (ASH) and the European Hematology Assocation (EHA) that is focused on helping scientists build successful careers in hematologic translational research, including pathogenesis, diagnostics, and experimental treatment of hematological disorders. Twenty early-career scientists from the U.S. and Europe will be selected to participate in the program, which begins with an intensive week-long course held … Read More

V Foundation cancer research funding, internal deadline April 5

The V Foundation for Cancer Research – Translational Awards provide up to $200,000 per year for three years to fund projects that intend to develop novel, translational approaches to the prevention, detection and treatment of human cancer. Collaboration of investigators from both the lab and clinic is required. Project teams must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise. One application is permitted … Read More

Tomasz Beer, M.D., to join Dream Team for prostate cancer research

OHSU researcher and Knight Cancer Institute Deputy Director Tomasz Beer, M.D., has been selected to participate in a prestigious, six-person Dream Team to fight advanced-stage prostate cancer. Funding for this collaborative initiative is provided by Stand Up to Cancer, the Prostate Cancer Foundation, and the American Association for Cancer Research. Dr. Beer will be working with researchers from four University of California campuses–San Francisco, Los Angeles, Santa Crus, and Davis–as well as the University of … Read More

Charles D. Blanke, M.D., chair-elect of SWOG, joins OHSU

OHSU’s Knight Cancer Institute has recruited Charles D. Blanke, M.D., chair-elect of SWOG, one of the largest National Cancer Institute-funded clinical trial networks. As leader of SWOG, Dr. Blanke will oversee $40 million in research funding annually. The Knight Cancer Institute is expected to benefit by receiving $20 to $25 million and increased access to SWOG clinical trials. Dr. Blanke’s recruitment supports the Knight Cancer Institute’s mission of being a leader in personalized cancer medicine. … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives